(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

PEPTÍDEO E COMPOSIÇÃO FARMACÊUTICA

Em AnáliseInvention PatentPCT · KR2023021392

Application data

Invention Patent PEPTÍDEO E COMPOSIÇÃO FARMACÊUTICA de HANMI PHARM. CO., LTD. — IPC A61K 38/00
Invention Patent PEPTÍDEO E COMPOSIÇÃO FARMACÊUTICA de HANMI PHARM. CO., LTD. — IPC A61K 38/00. Drawing published by the INPI in the Industrial Property Gazette.

Number

112025012492

Type

Invention Patent

Filing

12/22/2023

Publication

02/10/2026

PCT

KR2023021392

Progress at the INPI

Examination not yet requested
  1. Filing12/22/23
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

Examination has not been requested yet. Without that request by 12/22/2026, the application is definitively abandoned (art. 33 of the Brazilian IP Act).

Deadline to request examination:12/22/2026(119 days left)

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 02/10/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

HANMI PHARM. CO., LTD.

KR

See this company's full portfolio

Inventors

H. I. (pessoa física)

KR

J. K. (pessoa física)

KR

M. S. (pessoa física)

KR

Y. K. (pessoa física)

KR

Technical data

Priority claims

KR

10-2022-0182980 · 12/23/2022

Abstract

PEPTÍDEO E COMPOSIÇÃO FARMACÊUTICA. A presente invenção refere-se a um agonista trigonal inovador que tem atividade em todos os receptores de GLP-1, GIP e glucagon, e usos dos mesmos para a prevenção ou tratamento de obesidade.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

02/10/2026

RPI 2875

Alteração de dados cadastrais

#1.1

07/08/2025

RPI 2844

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.